Bio-Path Holdings, Inc.
(NASDAQ : BPTH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.58%179.391.2%$611.41m
CELGCelgene Corporation
1.25%77.571.2%$572.37m
GILDGilead Sciences, Inc.
0.49%68.160.9%$553.63m
BIIBBiogen Inc.
1.46%283.781.2%$528.24m
REGNRegeneron Pharmaceuticals, Inc.
0.10%294.972.6%$308.84m
ILMNIllumina, Inc.
0.31%271.643.5%$236.09m
VRTXVertex Pharmaceuticals Incorporated
0.14%156.501.9%$230.74m
ALXNAlexion Pharmaceuticals, Inc.
-0.71%118.172.0%$223.34m
AAgilent Technologies, Inc.
-0.60%64.451.5%$209.49m
NKTRNektar Therapeutics
0.04%81.986.0%$198.38m
INCYIncyte Corporation
0.27%66.742.5%$177.12m
SRPTSarepta Therapeutics, Inc.
-0.79%88.5216.6%$124.03m
BMRNBioMarin Pharmaceutical Inc.
1.90%89.274.4%$119.55m
EXASExact Sciences Corporation
-3.38%51.2025.5%$112.15m
BLUEBluebird Bio, Inc.
1.80%189.0015.7%$96.43m

Company Profile

Bio-Path Holdings, Inc. operates as a biotechnology company which focuses on the development of targeted therapies for acute myeloid leukemia, chronic myeloid leukemia, and other types of cancer. Its drug candidates include prexigebersen and Liposomal Bcl2. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein, and Ana Maria Tari on May 10, 2007 and is headquartered in Bellaire, TX.